Our purpose is to update the comprehensive ophthalmologist about the results of the Ocular Hypertension Treatment Study and the current clinical management of ocular hypertension. In the Ocular ...

If you suspect you have this condition, it should be immediately checked. While you can treat ocular hypertension and effectively bring down eye pressure, there is no cure for this condition.

In the Ocular Hypertension Treatment Study (OHTS) risk estimator, intraocular pressure is an independent variable and risk of developing glaucoma is the dependent variable. In the Threshold to ...

Glaucoma, the leading cause of blindness, is often marked by loss of retinal ganglion cells (RGCs). Necroptosis, a form of ...

Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension.

Himani Goyal, MD, discusses a complex glaucoma case involving persistent intraocular pressure elevation despite multiple treatment procedures, focusing on advanced management strategies and ...

Pravin U. Dugel, MD, Ocular’s Executive Chairman, President and CEO, will provide an update regarding the enrollment status of SOL-R, the Company’s second registrational trial of AXPAXLI™ for the ...

Dec. 10, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix ... in a Phase 2 clinical trial for the treatment of open-angle glaucoma or ocular hypertension. Follow the Company on its website, LinkedIn ...

Dec. 13, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix ... in a Phase 2 clinical trial for the treatment of open-angle glaucoma or ocular hypertension. Follow Ocular on its website, LinkedIn ...